Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.505 USD | -0.99% | -0.33% | -17.39% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 66.77M | Sales 2025 * | 82.57M | Capitalization | 173M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -38M | EV / Sales 2024 * | 2.59 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.09 x |
P/E ratio 2024 * |
-4.07
x | P/E ratio 2025 * |
-5.7
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.82% |
Latest transcript on Biodesix, Inc.
1 day | -3.18% | ||
1 week | -0.33% | ||
Current month | +22.58% | ||
1 month | +17.83% | ||
3 months | +3.40% | ||
6 months | +2.01% | ||
Current year | -17.39% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 11-02-28 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 08-05-31 |
Jack Schuler
BRD | Director/Board Member | 83 | 11-12-31 |
Jon Kayyem
BRD | Director/Board Member | 60 | 21-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 1.52 | 0.00% | 1 513 |
24-05-22 | 1.52 | -3.18% | 247,745 |
24-05-21 | 1.57 | 0.00% | 90,740 |
24-05-20 | 1.57 | -0.32% | 110,844 |
24-05-17 | 1.575 | +0.96% | 50,934 |
Delayed Quote Nasdaq, May 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.39% | 173M | |
-20.70% | 7.83B | |
+67.01% | 4.29B | |
-0.72% | 2.58B | |
-8.23% | 2.48B | |
-38.69% | 2.46B | |
-10.75% | 1.84B | |
-19.84% | 1.53B | |
-40.24% | 1.22B | |
+16.56% | 1.2B |
- Stock Market
- Equities
- BDSX Stock